Drug Indications Database™
Provides an Essential Component of Advanced Clinical Information Systems
HELPS PREVENT INAPPROPRIATE PRESCRIBING
Drug Indications Database™ assists in identifying the drugs available to treat a specific medical condition. In doing so, it also facilitates adherence to federal drug use standards, identifies potential off-label drug uses and drug contraindications associated with inappropriately prescribed medications.
FEATURES
- Drug acceptance level - differentiates between FDA-approved indications, officially recognized unlabeled uses and other known unlabeled uses
- Role of therapy - distinguishes between short-term use and maintenance drugs
- Outcome - specifies the “expected” clinical result subsequent to drug use
- Treatment rank - identifies a specific drug's rank in managing a particular medical condition, (e.g., first-line, alternate)
When applicable, the database also includes:- Microorganism code - identifies the microorganism that causes the medical condition
- Restricted medical condition - specifies drug indications limited to patients with a unique medical condition
- Co-treatment set - identifies drugs that must be used in combination
- Proxy - indicates the likelihood that a patient is taking a drug to manage a particular indication
BENEFITS
FOR HEALTH CARE FACILITIES
-
Allows health care providers to differentiate between labeled and common off-label drug uses
-
Assesses appropriate drug selection
-
Helps reduce or eliminate hospitalizations, physician office visits, drug therapy, lab tests and other costs associated with inappropriate drug selection
-
Optimizes therapeutic outcomes by identifying drugs that must be used in combination with other drugs to manage a condition
-
Supports “proxy” medical condition identification, enabling users to infer medical conditions based on drug therapy when other information is unavailable
- Click here to download the PDF
FOR HEALTH CARE PROVIDERS
-
Allowshealth care providers to differentiate between labeled and common off-label drug uses
-
Assesses appropriate drug selection
-
Helps reduce or eliminate hospitalizations, physician office visits, drug therapy, lab tests and other costs associated with inappropriate drug selection
-
Optimizes therapeutic outcomes by identifying drugs that must be used in combination with other drugs to manage a condition
-
Supports “proxy” medical condition identification, enabling users to infer medical conditions based on drug therapy when other information is unavailable
- Click here to download the PDF
FOR PAYERS
-
Allows payers to differentiate between labeled and common off-label drug uses
-
Provides OBRA '87 drug selection confirmation
-
Assesses appropriate drug selection
-
Helps reduce or eliminate hospitalizations, physician office visits, drug therapy, lab tests and other costs associated with inappropriate drug selection
-
Optimizes therapeutic outcomes by identifying drugs that must be used in combination with other drugs to manage a condition
-
Supports “proxy” medical condition identification, enabling users to infer medical conditions based on drug therapy when other information is unavailable
- Click here to download the PDF
FOR PHARMACISTS
-
Allows pharmacists to differentiate between labeled and common off-label drug uses
-
Provides long-term care pharmacists with OBRA '87 drug selection confirmation
-
Assesses appropriate drug selection
-
Helps reduce or eliminate hospitalizations, physician office visits, drug therapy, lab tests and other costs associated with inappropriate drug selection
-
Optimizes therapeutic outcomes by identifying drugs that must be used in combination with other drugs to manage a condition
-
Supports “proxy” medical condition identification, enabling users to infer medical conditions based on drug therapy when other information is unavailable
- Click here to download the PDF